COMMERCIAL VIABILITY ACADEMY
Two Days to Save Two Years™
Exclusive, invitation-only program for founders and investors presented by RQR Advisors
TWO DAYS. ONE OBJECTIVE:
DEFINE THE EXIT.
The Commercial Viability Academy is an exclusive, invitation-only program for founders and investors presented by RQR Advisors. This hands-on Academy educates founders and investors in new life science technologies on how Commercial Viability (“CV”) influences product development, investor confidence, and strategic acquisition.
Using real-world case studies, the Academy shows how commercial logic – not just technical milestones – determines the exit.
The Academy offers unparalleled access to former multinational executives, corporate development leaders, and cross-functional subject matter experts, all working together as they did inside Strategics.
It is designed for founders who value clarity before commitment and who desire fewer slide presentations and more interactive dialogue and debate. Attendees leave the Academy with a draft roadmap for focusing on their next moves in product development, fundraising, and partnerships and for what steps not to take in the process.
Agenda Overview*
Day 1: Perspective & Pressure
Inside the Strategic Mindset — how acquirers decide: assess, invest, acquire, or pass.
Seven Domains of CQ™ — self-guided teaching with real case studies to show how domains manage risk and create value.
Case Studies — tuck-ins, pull-through technologies, and transformative M&A.
Breakouts & Rotations — interactive dialogue with the council, applying domains to each participant’s narrative.
CQ Assessment — identify strengths, surface gaps, and build a personalized roadmap.
* Subject to variations.
Day 2: Inside the Boardroom
Strategic Staff Meeting Simulation — immersive half-day modeled on a strategic leadership review.
Product Development Review — dialogue with the council on how management teams assess readiness and progress.
Corporate Development Debate — where to place bets, when to lead a round, and how strategics decide advance, watch, or pass.
Management Deliberation — behind-closed-doors view of how senior leaders weigh commercial viability.
Seats are limited. Secure your invitation.
Define the exit. Now. It matters.
Commercial success doesn’t just happen at launch—it’s engineered from the first milestone. The CV Academy opens a window into how acquirers think and decide. Participants leave with a sharper lens on their strategy, a candid view of the gaps, and a foundation built with commercial viability as the guide toward a defined exit.
Two Days. One Objective: Define the Exit.
What is your product's path to commercial viability? Your technology’s future isn’t about features—it’s about its fit inside an acquirer’s portfolio. The Academy is where you see, test, and shape that reality.
By invitation or referral only
InterContinental Minneapolis–St. Paul Airport
Location
2 days
Event Duration
December 5-6, 2025
Next Dates
$15,000
Pricing
(up to 3 participants, space permitted)
Commercial Viability Defines the Exit.
The Academy educates founders and investors in new life science technologies on how Commercial Viability (CV) influences product development, investor confidence, and strategic acquisition. Using real-world case studies, the Academy shows how commercial logic—not just technical milestones—determines the exit.
“What I value about RQR is their experience as well as their candor. They’ll tell you if a technology is commercially viable—or not.”
What Makes This Different
Unparalleled Access: The Commercial Viability Council — corporate development leaders, and cross-functional experts — working together as they did inside Strategics.
Closest to the Boardroom: A collaborative discussion and debate on commercial viability — weighing portfolio fit, portfolio leverage, adoption dynamics, evidence & economics, manufacturability, and market defensibility in one discussion.
Cross-Functional Lens: If an unmet clinical need commands a price, it must also deliver margin, align with reimbursement, and prove procedural economics for patients, physicians, providers, and payers. The Council exposes those interdependencies.
Interactive Design: Minimal slides, maximum dialogue. Case-based learning, live debate, and simulations make the process tangible.
Authentic Simulation: Full-spectrum reviews — R&D, Regulatory, Clinical, Quality, Reimbursement, and Manufacturing — alongside Corporate Development debates, modeled after real processes inside multinational Strategics.
What You’ll Leave With
A working understanding of the 7 Domains of Commercial Quotient™ (CQ) and why each defines commercial viability — and ultimately, the exit.
A guided self-assessment across the domains to surface where strengths are clear and where gaps are likely.
A draft roadmap to focus your next moves in product development, fundraising, and partnerships — grounded in commercial logic.
Direct exposure to the Commercial Viability Council as they debate how Strategics decide whether to invest, acquire, or pass.
Key Learning Objectives
Commercial Viability is not abstract—it shapes every decision. The Academy shows how CV guides product development and exit design, why investors demand proof before committing capital, and how Strategics apply CV in acquisition decisions. The direct link between CV, development choices, and long-term value becomes unmistakable.
Impact on Founders & Boards
For founders and boards, CV reframes the essentials of governance.
What is the CV of our device?
Are we using it to shape our development plan?
Do investors fully understand it?
And most critically, do we know how Strategics will evaluate it?
The Academy reveals a hard truth: product progress is only meaningful if it advances commercial viability—and ultimately, a defined exit.
“For the first time, I can see my company the way an acquirer would. It’s eye-opening, and honestly, a little humbling.”